An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)
This study will examine the effect of BIIB021 on GIST growth and metabolism.
GIST
DRUG: BIIB021
Changes in FDG-PET imaging, 28 days
Characterize the safety profile of BIIB021, Duration of study
This study will examine the effect of BIIB021 on GIST growth and metabolism.